Such tumor antigen-targeting antibody-dependent cellular phagocytosis is observed to be more superior in TCMs and M1 (IFNγ + LPS) macrophages as compared to M2 macrophages (IL-4 + IL-13) (Grugan et al., 2012). The gene discussed is IFNG; the disease is neoplasm.